Photo: CC2.0 Sandra Koch via pixabay

Conditions attached to Dutch government investments in corona vaccines and medication to guarantee affordability and accessibility are are insufficient at best and, at worst, counterproductive. Vaccine manufacturing companies are able to negotiate conditions into the financing agreements that relieve them of any responsibility if something goes wrong.

This is what SOMO has revealed through research into the investment contracts between the Dutch government and companies corona vaccine development.

Read more in Dutch>